uniQure NV (QURE)
5.34
-0.07
(-1.29%)
USD |
NASDAQ |
Mar 28, 10:44
uniQure Enterprise Value: -257.34M for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | -257.34M |
March 26, 2024 | -261.64M |
March 25, 2024 | -260.21M |
March 22, 2024 | -263.56M |
March 21, 2024 | -267.86M |
March 20, 2024 | -265.95M |
March 19, 2024 | -270.73M |
March 18, 2024 | -278.39M |
March 15, 2024 | -268.82M |
March 14, 2024 | -285.56M |
March 13, 2024 | -271.69M |
March 12, 2024 | -269.78M |
March 11, 2024 | -270.25M |
March 08, 2024 | -266.43M |
March 07, 2024 | -263.56M |
March 06, 2024 | -268.34M |
March 05, 2024 | -275.04M |
March 04, 2024 | -269.30M |
March 01, 2024 | -248.73M |
February 29, 2024 | -241.07M |
February 28, 2024 | -196.10M |
February 27, 2024 | -193.23M |
February 26, 2024 | -210.93M |
February 23, 2024 | -213.80M |
February 22, 2024 | -215.75M |
Date | Value |
---|---|
February 21, 2024 | -216.70M |
February 20, 2024 | -217.18M |
February 16, 2024 | -236.32M |
February 15, 2024 | -254.01M |
February 14, 2024 | -263.10M |
February 13, 2024 | -261.67M |
February 12, 2024 | -231.53M |
February 09, 2024 | -232.49M |
February 08, 2024 | -254.49M |
February 07, 2024 | -247.80M |
February 06, 2024 | -231.05M |
February 05, 2024 | -256.88M |
February 02, 2024 | -258.32M |
February 01, 2024 | -250.19M |
January 31, 2024 | -250.19M |
January 30, 2024 | -240.62M |
January 29, 2024 | -229.62M |
January 26, 2024 | -237.27M |
January 25, 2024 | -240.62M |
January 24, 2024 | -245.88M |
January 23, 2024 | -236.08M |
January 22, 2024 | -243.49M |
January 19, 2024 | -250.67M |
January 18, 2024 | -252.10M |
January 17, 2024 | -243.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-288.31M
Minimum
Oct 27 2023
2.931B
Maximum
Jun 21 2019
1.064B
Average
834.76M
Median
Enterprise Value Benchmarks
ProQR Therapeutics NV | 66.91M |
Merus NV | 2.257B |
argenx SE | 20.45B |
Pharming Group | 648.46M |
Pharvaris NV | 795.49M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -73.21M |
Revenue (Quarterly) | 6.689M |
Total Expenses (Quarterly) | 68.44M |
EPS Diluted (Quarterly) | -1.53 |
Gross Profit Margin (Quarterly) | -32.08% |
Profit Margin (Quarterly) | -1.09K% |
Earnings Yield | -121.3% |
Normalized Earnings Yield | -120.64 |